skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

The report features real-time analysis and insights from Biomedtracker and Meddevicetracker to help you decode the impact of upcoming events and trends and make faster, better informed decisions.

Stay one step ahead with the latest data and analyst intelligence on the game-changing drugs, devices, diagnostics and deals expected this quarter in the recently published Q4 2020 Outlook Report.

 

Q4 Outlook Report 2020: Extract

Download your sample report now to get a first look at critical market events coming in Q4 that will shape the pharmaceutical industry.

The report extract from the Q4 2020 Outlook Report or the latest in-depth intelligence on the drug, device and diagnostic catalysts that occurred in Q3 2020, with updates on Likelihood of Approval (LOA). This excerpt features data from Biomedtracker and Meddevicetracker. 

 

q4 Outlook report

Q4 Outlook Report 2020

Stay one step ahead with the latest data and analyst intelligence on the game-changing drugs, devices, diagnostics and deals expected this quarter in the recently published Q4 2020 Outlook Report.

 

q4 Outlook report

Q4 2020 Outlook Report: Infographic

Get a taster of the analysis available to you with the free Q3 Catalyst Roundup infographic.

You’ll be able to see the outcomes of two key catalysts featured in the Q3 Outlook Report and find out how recent events are affecting what’s in store for these drugs. Download the free Catalyst Roundup infographic to follow the outcomes of two key catalysts featured in our Q3 Outlook Report. This infographic brings you up with recent events and how they affect what’s in store for these drugs and the companies behind them.

MDT Infographic 2020 Q4

Read also

  • Biomedtracker: see the drug development process through anal...

    Key Potential Drug Launches in 2022

    Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.

  • Biomedtracker: see the drug development process through anal...

    2020 Deal-Making Roundup

    Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

    Topics Drug Review Coronavirus

  • Biomedtracker: see the drug development process through anal...

    Q3 2021 Outlook Report

    What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

    Topics Drug Review

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: